Clinical trial Recruiting at 1 site Interventional Ages 40 to 65

Isometric Strengthening vs. Tens in Diabetic Shoulder Pain

Official title: Isometric Strengthening Exercises Versus Tens in Management of Shoulder Pain in Diabetic Population

Run by Kafrelsheikh University · NCT07747454 · Data updated 2026-11-12

This study tests whether isometric strengthening exercises or transcutaneous electrical nerve stimulation help reduce shoulder pain in people with diabetes.

Quick facts

Study typeInterventional
Ages40 Years to 65 Years
SexAll
Enrollment75 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Kafr ash Shaykh)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedAugust 5, 2026
Trial IDNCT07747454 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40-65 with type 2 diabetes for at least 5 years and a clinical diagnosis of unilateral frozen shoulder in the painful or stiff stage.

Probably not a fit

Patients with prior shoulder surgery, cervical radiculopathy, rheumatoid arthritis, severe osteoarthritis, pacemakers, recent corticosteroid injections, type 1 diabetes, or vitamin deficiencies may not benefit from these interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two non-drug approaches for managing shoulder pain in adults with type 2 diabetes. Participants will have unilateral frozen shoulder with limited range of motion and at least three months of pain, and will be assigned to either isometric strengthening exercises, transcutaneous electrical nerve stimulation, or a conventional exercise program. Outcomes focus on pain modulation and functional recovery to inform rehabilitation strategies for diabetes-related shoulder issues. The trial aims to determine which approach offers better pain relief and mobility without relying on analgesics. Results could guide non-pharmacologic treatment options for diabetic patients with shoulder complications.

Why it matters

Potential benefit: If successful, participants could experience improved shoulder pain and function through non-pharmacologic therapies, potentially reducing dependence on analgesics.

How similar studies have gone: Previous research supports non-pharmacologic approaches for shoulder pain, but direct comparisons between isometric exercises and TENS in diabetes-related shoulder pain are limited, making this study relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 40-65 years, diagnosed as type 2 diabetes mellitus for at least 5 years
* Clinical diagnosis of unilateral frozen shoulder in the painful or stiff stage.
* Limitation of passive and active range of motion in external rotation, abduction, and flexion.
* Shoulder pain for at least 3 months.

Exclusion Criteria:

* Previous shoulder surgery or fracture.
* Cervical radiculopathy or neurological disorders.
* Rheumatoid arthritis or severe osteoarthritis.
* Cardiac pacemaker.
* Received corticosteroid injection within the last 3 months.
* diabetes mellitus type 1
* Participants with Vitamin B12 or D deficiency
* Osteoarthritis

Where it's running

  • Out-Patient Clinic, Faculty of Physical Therapy, Kafrelsheikh University
    Kafr ash Shaykh, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.